A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED, PHASE 3B STUDY TO EVALUATE THE SAFETY AND EFFICACY OF BENRALIZUMAB 30MG SC IN PATIENTS WITH SEVERE ASTHMA UNCONTROLLED ON STANDARD OF CARE TREATMENT
Principal Investigator(s)
Maselli Caceres, Diego J
Funded by
ASTRAZENECA LP
Research Start Date
Status
Active